BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35609322)

  • 1. Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma.
    Wang C; Liang H; Li Y; Tang Z; Zhang Y
    Bioengineered; 2022 May; 13(5):12738-12748. PubMed ID: 35609322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
    Lin Z; Li W; Zhang H; Wu W; Peng Y; Zeng Y; Wan Y; Wang J; Ouyang N
    Tumour Biol; 2016 Mar; 37(3):3461-8. PubMed ID: 26449829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
    Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
    J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting FOXO1.
    Cheng Z; Cheng N; Tang X; Yang F; Ma W; Yu Q; Tang H; Xiao Q; Lei Z
    Exp Cell Res; 2023 Oct; 431(1):113741. PubMed ID: 37549804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine
    Ding D; Zhang L; Liu X; Sun C; He J; Li J; Gao X; Guan F; Zhang L
    J Interferon Cytokine Res; 2022 Jan; 42(1):19-28. PubMed ID: 35041514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses.
    Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A
    FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin Inhibits Intrahepatic Cholangiocarcinoma by Inducing Ferroptosis and Inhibiting Invasion via the NF-[Formula: see text]B Pathway.
    Song Y; Zhang Z; Chai Q; Zheng H; Qi Y; Xia G; Yu Z; Yang R; Huang J; Li Y; Peng C; Jiang B; Liu S
    Am J Chin Med; 2023; 51(3):701-721. PubMed ID: 36823098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.
    Zhou M; Yu H; Bai M; Lu S; Wang C; Ke S; Huang J; Li Z; Xu Y; Yin B; Li X; Feng Z; Fu Y; Jiang H; Ma Y
    Cancer Sci; 2024 Mar; 115(3):777-790. PubMed ID: 38228495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway.
    Zhang H; Yang J; Song Q; Ding X; Sun F; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):199-209. PubMed ID: 38298057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of FGFR3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma.
    Chen YH; Yang SH; Liu LX; Hu S; Wang XJ; Liao ZJ; Huan YF; He K; Zhang XW
    Dig Liver Dis; 2023 Mar; 55(3):400-406. PubMed ID: 35999136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fascin Overexpression Promotes Cholangiocarcinoma RBE Cell Proliferation, Migration, and Invasion.
    Zhao H; Yang F; Zhao W; Zhang C; Liu J
    Technol Cancer Res Treat; 2016 Apr; 15(2):322-33. PubMed ID: 25882880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
    Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
    Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.
    Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S
    Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
    Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
    Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
    Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
    Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOV/CCN3 Promotes Cell Migration and Invasion in Intrahepatic Cholangiocarcinoma via miR-92a-3p.
    Liang T; Shen L; Ji Y; Jia L; Dou Y; Guo L
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
    Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
    Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.